Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20903956 | 0.90 | ALDH1A1 (0.48) | ALDH1A1TSHRTDP1LMNACYP3A4 | |
| SCHEMBL18107415 | 0.88 | ALDH1A1 (0.62) | ALDH1A1TSHRTDP1LMNACYP3A4 | |
| SCHEMBL18107452 | 0.88 | LMNA (0.50) | ALDH1A1TSHRTDP1LMNACYP3A4 | |
| SCHEMBL18107323 | 0.88 | LMNA (0.50) | ALDH1A1TSHRTDP1LMNACYP3A4 | |
| SCHEMBL18107450 | 0.88 | LMNA (0.50) | ALDH1A1TSHRTDP1LMNACYP3A4 | |
| SCHEMBL18107363 | 0.88 | LMNA (0.50) | ALDH1A1TSHRTDP1LMNACYP3A4 | |
| SCHEMBL18184661 | 0.88 | ALDH1A1 (0.62) | ALDH1A1TSHRTDP1LMNACYP3A4 | |
| SCHEMBL18107253 | 0.85 | ALDH1A1 (0.46) | ALDH1A1TSHRTDP1LMNACYP3A4 | |
| SCHEMBL18184497 | 0.85 | ALDH1A1 (0.52) | ALDH1A1TSHRTDP1LMNACYP3A4 | |
| SCHEMBL11676287 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0740679-B1 | CROSSLINKED POLYMERIC AMMONIUM SALTS | DU PONT (US) | 2001-08-08 | — | — | EP | claimed |
| US-5874522-A | FORMING CROSSLINKED POLYMERIC AMMONIUM SALT OR POLYMERIC AMINE IN SOLVENT, WHEREIN TEMPLATE COMPRISING SACCHARIDE OR ORGANIC METAL SALT IS PRESENT WHEN THE CROSSLINKED POLYMERIC AMMONIUM SALT OR POLYMERIC AMINE GELS; BILE ACID SEQUESTRANTS | DUPONT PHARMACEUTICALS COMPANY (US) | 1999-02-23 | — | — | US | claimed |
| US-5726284-A | Crosslinked polymric ammonium salts | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-03-10 | — | — | US | claimed |
| EP-0740679-A1 | CROSSLINKED POLYMERIC AMMONIUM SALTS | E.I. DU PONT DE NEMOURS & COMPANY INCORPORATED (US) | 1996-11-06 | — | — | EP | claimed |
| US-5556619-A | BILE ACID SEQUESTERANTS TO LOWER BLOOD CHOLESTEROL, POLYAMINES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-09-17 | — | — | US | claimed |
| WO-1995019384-A1 | CROSSLINKED POLYMERIC AMMONIUM SALTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-07-20 | — | — | WO | claimed |